Authors

• Ubirajara Ferreira (ORCID: https://orcid.org/0000-0001-6477-5153)
• Luke T. Nordquist
• Christopher Pieczonka (ORCID: https://orcid.org/0000-0002-2531-7587)
• Jeff Saranchuk
• Brad Rosbrook
• Yiyun Tang (ORCID: https://orcid.org/0000-0001-9810-1288)
• Stephen J. Freedland (ORCID: https://orcid.org/0000-0002-8104-6419)
• Antti Rannikko (ORCID: https://orcid.org/0000-0002-4261-3484)
• Klaus Brasso (ORCID: https://orcid.org/0000-0001-6562-6416)
• Fabian Zohren
• Martin Gleave (ORCID: https://orcid.org/0000-0003-4235-0167)
• Swetha Sridharan (ORCID: https://orcid.org/0000-0001-6337-8543)
• Antonio Gómez‐Caamaño (ORCID: https://orcid.org/0000-0002-9773-4590)
• Ugo De Giorgi (ORCID: https://orcid.org/0000-0001-7520-2908)
• Henry Hyunshik Woo (ORCID: https://orcid.org/0000-0003-4099-0339)
• Jamal Tarazi (ORCID: https://orcid.org/0000-0002-5452-2061)
• Neal D. Shore (ORCID: https://orcid.org/0000-0001-5767-0548)
• Gabriel P. Haas
• Matt Rosales

Institutions

• University of Copenhagen (DK)
• Cedars-Sinai Medical Center (US)
• University of Helsinki (FI)
• University of British Columbia (CA)
• Pfizer (United States) (US)
• Universidade Estadual de Campinas (UNICAMP) (BR)
• Helsinki University Hospital (FI)
• Blacktown & Mount Druitt Hospital (AU)
• Copenhagen University Hospital (DK)
• Rigshospitalet (DK)
• CancerCare Manitoba (CA)
• Chris O’Brien Lifehouse (AU)
• Complejo Hospitalario Universitario de Santiago (ES)
• Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT)
• Durham VA Medical Center (US)
• Calvary Mater Newcastle Hospital (AU)
• Clinical Research Associates (US)
• Istituti di Ricovero e Cura a Carattere Scientifico (IT)
• Nebraska Cancer Specialists (US)
• Carolina Urologic Research Center (US)
• Astellas Pharma (United States) (US)

Publication Details

Journal

The Journal of Urology

Published

2025-12-09

DOI

https://doi.org/10.1097/ju.0000000000004890

Primary Topic

Prostate Cancer Treatment and Research

Type

article

Field-Weighted Citation Impact

0.00